Molecular Cytogenetics Market Size by Technique (Fluorescence In Situ Hybridization, Comparative Genomic Hybridization, In situ Hybridization, Karyotyping, and Banding Techniques), by Product (Instruments, Kits and Reagents, Software, Services and Consumables/Accessories ), by Application (Oncology, Genetic Disorders, Personalized Medicines, and others), by End User (Pharmaceuticals and Biotechnology Companies, Clinical and Diagnostic Laboratories, and Academic Institutes) - Global Forecast to 2022

The molecular cytogenetics market is expected to reach USD 2,266.4 million by 2022, at a CAGR of 11% during the forecast period of 2017 to 2022.

Following a comprehensive research on molecular cytogenetics and an in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, trends, and opportunities, listed in the market dynamics segment. Increasing focus on preventive healthcare measures, growing genetic abnormalities, increasing aging population and subsequent rise in various chronic diseases, growing need to reduce mounting healthcare cost, and increasing focus on clinical and research diagnosis are the key market drivers covered in the report which will support the industry growth in the forecast period. However, lack of awareness about diagnostic technologies, high cost of diagnosis, unfavorable reimbursement scenario within the molecular cytogenesis, and technical limitations and complexities of the equipment are the major pain points, restraining the adoption of this technology.

The report further gives an extensive outlook on the multifarious verticals/industries served by the molecular cytogenetics techniques. These industries include healthcare, pharmaceutical, biotechnological, and others. The verticals/industry segment further briefly talks about the trends impacting the growth of these markets and the benefits involved with the use molecular cytogenetics techniques in these verticals to improve overall accuracy of disease diagnosis.

Click here to: Get Free Request Sample Copy of this report

An exhaustive analysis of the geographical scenario of the industry for the five major geographies: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa are included in the geographical analysis section. These regions are further analyzed at a country level with the detailed qualitative and quantitative analysis. The geographical analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the demographic & economic impact, government & private investments, and regulatory scenario. The report identifies North America to be the largest market followed by Europe, Asia Pacific, and Rest of World. The geographical analysis section also comments on the key market players shaping the growth of the industry in the respective countries.

The report also includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 3 years (2014-2017).

The key players operating in the global molecular cytogenetics market are Thermo Fisher Scientific (U.S.), Abbott Laboratories (U.S.), Agilent Technologies (U.S.), PerkinElmer (U.S.), Bio-Rad Laboratories (U.S.), Applied Spectral Imaging (U.S.), Quest Diagnostics (U.S.), Roche Diagnostics (Switzerland) , Danaher Corporation (U.S.), Illumina (U.S.), and Oxford Gene Technology (U.S.).

Scope of Molecular Cytogenetics Market report

Market by Techniques:

• Fluorescence In Situ Hybridization
• Comparative Genomic Hybridization (CGH)
  • Chromosomal CGH
  • Array-Based CGH
• In Situ Hybridization
• Karyotyping
  • Spectral Karyotyping
  • Virtual Karyotyping
• Banding Techniques
  • G banding
  • Q banding
  • R banding
  • C banding
  • T banding

Market by Product:

• Instruments
  • Systems
  • Imagers and Scanners
• Kits and Reagents
  • Testing Kits
  • Probes
  • Reagents
• Software
• Services
• Consumables/Accessories

Market by Application:

• Oncology
• Genetic Disorders
• Personalized Medicines
• Others

Market by End Users:

• Pharmaceutical and Biotechnological companies
• Clinical and Diagnostic laboratories
• Academic Institutes
• Others

Market by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of APAC (RoAPAC)
• Latin America
• Middle East & Africa

Key questions answered in Molecular Cytogenetics Market report: 

Growing pharmaceutical and biotechnology industry help to drive the adoption of molecular cytogenetics

• How does the penetration of molecular cytogenetic techniques in pharmaceutical and biotechnological industry differ from other end users?
• What impact does this have on the adoption of molecular cytogenetic techniques in comparison to other niche applications and end users?
• Which are the high growth market segments in terms of techniques, product, applications, end-users,and regions/countries? 

Academic Institutes accounts for a relatively small proportion of all end users of molecular cytogenetics globally

• What factors contribute to the growth of usage of molecular cytogenetics in academic institutes?
• What factors contribute to the infrequent usage of molecular cytogenetic techniques in academic institutes?
• Conversely, which geographic segment is expected to experience the fastest growth of academic institutes? 

The North American molecular cytogenetics market favours both larger and local manufacturers that compete in multiple segments

• Who are the top competitors in this market and what strategies do they employ to gain shares?
• Which segments of the molecular cytogenetics market are expected to offer lucrative revenue growth over the forecast period and why?
• What strategies should the new companies focus to enter this market and to compete effectively?
• What are the major drivers, restraints, opportunities, and trends in the global molecular cytogenetics market?
• Who are the major players in various countries and what share of the market do they hold?
• What are the geographic trends and high growth regions/ countries? 

Recent partnerships, acquisitions, and expansions have taken place in the molecular cytogenetics space.

• What companies have recently merged/acquired and how will these unions affect the competitive landscape of the molecular cytogenetics space?
• What companies have created partnerships and how will these partnerships promote a competitive advantage?
• Who are the major players in the global molecular cytogenetics and what share of the market do they hold?
• What are the local emerging players in the global molecular cytogenetics and how do they compete with the global players?